Riskpilot← Back to searchSign inGet full accessEAF Procedius K/S
K/SActiveCVR 38350102Amaliegade 6, 2. tvActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -25K
0% vs 2023
EBITDA margin
100.0%
+100% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
DKK -33K
+99% vs 2023
| Revenue | DKK -25K | +0% |
| EBITDA | DKK -25K | +100% |
| Net profit | DKK -33K | +99% |
| Total assets | DKK 31M | +11% |
| Equity | DKK 31M | +11% |
| Employees | — | — |
Legal name
EAF Procedius K/S
CVR number
38350102
Legal form
Kommanditselskab
NACE code
6421 · Activities of holding companies
Founded
20. januar 2017
Share capital
DKK 0
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Kommanditselskabet tegnes af komplementaren.
Company purpose
Kommanditselskabets formål er at generere indkomst og formueforøgelse ved at yde egenkapitals- og kvasi-egenkapitalsfinansiering til innovative selskaber i Danmark og i udlandet samt al virksomhed, der har forbindelse hermed.
Address
Amaliegade 6, 2. tv
Phone
+4545484448
Email
jbb@jusmedico.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -25 | -47 | -12 | -44 | -44 | -44 | -25 | -25 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -25 | -47 | -12 | -6.420 | -44 | -44 | -8.980 | -25 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -25 | -47 | -12 | -6.420 | -44 | -44 | -8.980 | -25 |
| Net financials | -0 | -12 | -11 | -9 | 823 | -4 | 4.469 | -8 |
| Profit before tax | -25 | -59 | -24 | -6.430 | 780 | -48 | -4.511 | -33 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -25 | -59 | -24 | -6.430 | 780 | -48 | -4.511 | -33 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 15.080 | 27.298 | 33.887 | 31.798 | 32.509 | 32.510 | 28.032 | 31.031 |
| Equity | 14.985 | 27.273 | 33.868 | 31.779 | 32.490 | 32.492 | 28.013 | 31.013 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 95 | 25 | 19 | 19 | 19 | 19 | 19 | 19 |
| Total debt | 95 | 25 | 19 | 19 | 19 | 19 | 19 | 19 |
EBITDA margin
-2500000.0%
This company
15.8%
Market median
-15822885% vs market
20172024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20172024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20172024
Net profit margin
-3319700.0%
This company
8.1%
Market median
-40984051% vs market
20172024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-20 – 2017-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ADSIDIUS ApS | Company | 50.0% | 50.0% | 2017 |
| Individual | 50.0% | 50.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EAF Procedius K/S 
UNION therapeutics A/SBoard members of EAF Procedius K/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|